- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
CytRx Corp+ Add to Watchlist
CYTR:US2.9000 USD 0.0200 0.68%
As of 20:10:00 ET on 09/17/2014.
Company Profile for CytRx Corp (CYTR)
CytRx Corporation is a biopharmaceutical research and development company. The Company focuses in the development of high-value human therapeutics, specializing in oncology. CytRx is also developing two drug candidates based on its molecular chaperone regulation technology.
Key Executives for CytRx Corp (CYTR)
|Steven A KriegsmanPresident/CEO||Jean-Yves Caloz "John"CFO/Treasurer|
|Benjamin S LevinSenior VP/Gen Counsel/Secretary||Scott WielandSenior VP:Drug Development|
|Scott D GeyerSenior VP:Manufacturing||David J HaenVP:Business Development|
|Shanta ChawlaVP:Clinical Development||Felix KratzVP:Drug Discovery|